| 000 | 01801 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517124639.0 | ||
| 264 | 0 | _c20170829 | |
| 008 | 201708s 0 0 eng d | ||
| 022 | _a1097-6825 | ||
| 024 | 7 |
_a10.1016/j.jaci.2016.09.043 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOkubo, Kimihiro | |
| 245 | 0 | 0 |
_aEfficacy and safety of the SQ house dust mite sublingual immunotherapy tablet in Japanese adults and adolescents with house dust mite-induced allergic rhinitis. _h[electronic resource] |
| 260 |
_bThe Journal of allergy and clinical immunology _cJun 2017 |
||
| 300 |
_a1840-1848.e10 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAllergens _xadministration & dosage |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntigens, Dermatophagoides _xadministration & dosage |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin E _ximmunology |
| 650 | 0 | 4 | _aJapan |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPyroglyphidae _ximmunology |
| 650 | 0 | 4 |
_aRhinitis, Allergic _xtherapy |
| 650 | 0 | 4 |
_aSublingual Immunotherapy _xadverse effects |
| 650 | 0 | 4 | _aTablets |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aMasuyama, Keisuke | |
| 700 | 1 | _aImai, Toru | |
| 700 | 1 | _aOkamiya, Kazuhiro | |
| 700 | 1 | _aStage, Brian Sonne | |
| 700 | 1 | _aSeitzberg, Dorthe | |
| 700 | 1 | _aKonno, Akiyoshi | |
| 773 | 0 |
_tThe Journal of allergy and clinical immunology _gvol. 139 _gno. 6 _gp. 1840-1848.e10 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jaci.2016.09.043 _zAvailable from publisher's website |
| 999 |
_c26619624 _d26619624 |
||